PTC Therapeutics
PTCT
#2894
Rank
โ‚น582.48 B
Marketcap
โ‚น6,979
Share price
3.47%
Change (1 day)
58.49%
Change (1 year)

Earnings for PTC Therapeutics (PTCT)

Earnings in 2026 (TTM): -โ‚น20.86 Billion

According to PTC Therapeutics 's latest financial reports the company's current earnings are โ‚น0.82 Billion. In 2025 the company made an earning of โ‚น66.31 Billion, an increase over its 2024 earnings that were of -โ‚น34.57 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for PTC Therapeutics from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น20.86 Billion-131.45%
2025 โ‚น66.31 B-291.84%
2024 -โ‚น34.57 Billion-47.84%
2023 -โ‚น66.27 Billion18.49%
2022 -โ‚น55.93 Billion13.34%
2021 -โ‚น49.35 Billion28.64%
2020 -โ‚น38.36 Billion67.94%
2019 -โ‚น22.85 Billion87.28%
2018 -โ‚น12.2 Billion64.95%
2017 -โ‚น7.4 Billion-45.13%
2016 -โ‚น13.48 Billion-16.72%
2015 -โ‚น16.19 Billion72.64%
2014 -โ‚น9.38 Billion90.89%
2013 -โ‚น4.91 Billion96.58%
2012 -โ‚น2.5 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚น1.502 T-6,797.47%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
โ‚น481.89 B-2,247.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚น16.19 Billion-27.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น2.32 B-110.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
-โ‚น13.28 Billion-40.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-โ‚น65.18 Billion 190.50%๐Ÿ‡บ๐Ÿ‡ธ USA